RAS oncogenes: The first 30 years

Nature Reviews Cancer

Volumn 3, Issue 6, 2003, Pages 459-465

  Malumbres, Marcos ^a   Barbacid, Mariano ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; RAS PROTEIN;

ANIMAL CELL; CELL TRANSFORMATION; HUMAN; HUMAN CELL; ISOPRENYLATION; MOLECULAR CLONING; NONHUMAN; ONCOGENE K RAS; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; VIRUS GENOME; VIRUS RECOMBINANT; ANIMAL; ARTICLE; HISTORY; MEDICAL RESEARCH;

ANIMALS; BIOMEDICAL RESEARCH; GENES, RAS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 0037805547     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1097     Document Type: Review

References (119)

1. Harvey, J. J. An unidentified virus which causes the rapid production of tumors in mice. Nature 204, 1104-1105 (1964).
2. Kirsten, W. H. & Mayer, L. A. Morphologic responses to a murine erythroblastosis virus. J. Natl Cancer Inst. 39, 311-335 (1967).
3. Peters, R. L., Rabstein, L. S., VanVleck, R., Kelloff, G. J. & Huebner, R. J. Naturally occurring sarcoma virus of the BALB/cCr mouse. J. Natl Cancer Inst. 53, 1725-1729 (1974).
4. Rasheed, S., Gardner, M. B. & Huebner, R. J. In vitro isolation of stable rat sarcoma viruses. Proc. Natl Acad. Sci. USA 75, 2972-2976 (1978).
5. Scolnick, E. M., Rands, E., Williams, D. & Parks, W. P. Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J. Virol. 12, 458-463 (1973).
6. Hager, G. L. et al. Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization. J. Virol. 31, 795-809 (1979).
7. Tsuchida, N. & Uesugi, S. Structure and functions of the Kirsten murine sarcoma virus genome: molecular cloning of biologically active Kirsten murine sarcoma virus DNA. J. Virol. 38, 720-727 (1981).
8. Ellis, R. W. et al. The p21 src genes of Harvey and Kirsten murine sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 292, 506-511 (1981).
9. Wigler, M., Pellicer, A., Silverstein, S. & Axel, R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14, 725-731 (1978).
10. Shih, C., Shilo, B. Z., Goldfarb, M. P., Dannenberg, A. & Weinberg, R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl Acad. Sci. USA 76, 5714-5718 (1979).
11. Shih, C., Padhy, L. C., Murray, M., & Weinberg, R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290, 261-264 (1981).
12. Perucho, M. et al. Human-tumor-derived cell lines contain common and different transforming genes. Cell 27, 467-476 (1981).
13. Shih, C. & Weinberg, R. A. Isolation of a transforming sequence from a human bladder sarcoma cell line. Cell 29, 161-169 (1982).
14. Goldfarb, M., Shimizu, K., Perucho, M. & Wigler, M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296, 404-409 (1982).
15. Pulciani, S. et al. Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad. Sci. USA 79, 2845-2849 (1982).
16. Der, C. J., Krontiris, T. G. & Cooper, G. M. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc. Natl Acad. Sci. USA 79, 3637-3640 (1982).
17. Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras. Nature 297, 474-478 (1982).
18. Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S. & Barbacid, M. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature 298, 343-347 (1982).
19. Parada, L. F. & Weinberg, R. A. Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene. Mol. Cell. Biol. 3, 2298-2301 (1983).
20. Shimizu, K., Goldfarb, M., Perucho, M. & Wigler, M. Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc. Natl Acad. Sci. USA 80, 383-387 (1983).
21. Hall, A., Marshall, C. J., Spurr N. K. & Weiss, R. A. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature 303, 396-400 (1983).
22. Reddy E. P., Reynolds, R. K., Santos, E. & Barbacid, M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300, 149-152 (1982).
23. Tabin, C. J. et al. Mechanism of activation of a human oncogene. Nature 300, 143-147 (1982).
24. Taparowsky, E. et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300, 762-765 (1982).
25. Muschel, R. J., Khoury, G., Lebowitz, P., Koller, R. & Dhar, R. The human c-ras1H oncogene: a mutation in normal and neoplastic tissue from the same patient. Science 219, 853-856 (1983).
26. Duesberg, P. H. Activated proto-onc genes: sufficient or necessary for cancer? Science 226, 669-677 (1985).
27. Land, H., Parada, L. F. & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
28. Newbold, R. F. & Overell, R. W. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 304, 648-651 (1983).
29. Ruley, H. E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602-606 (1983).
30. Santos, E. et al. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 223, 661-664 (1984).
31. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689 (1989).
32. Bos, J. L. et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 327, 293-297 (1987).
33. Forrester, K., Almoguera, C., Han, K., Grizzle, W. E. & Perucho, M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327, 298-303 (1987).
34. Rodenhuis, S. et al. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med. 317, 929-935 (1987).
35. Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554 (1988).
36. Balmain, A. & Pragnell, I. B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303, 72-74 (1983).
37. Sukumar, S., Notario, V., Martin-Zanca, D. & Barbacid, M. Induction of mammary carcinomas in rats by nitroso-methyl-urea involves the malignant activation of the H-ras-1 locus by single point mutations. Nature 306, 658-661 (1983).
38. Guerrero, I., Calzada, P., Mayer, A. & Pellicer, A. A molecular approach to leukemogenesis: mouse lymphomas contain an activated c-ras oncogene. Proc. Natl Acad. Sci. USA 81, 202-205 (1984)
39. Parks, W. P. & Scolnick, E. M. In vitro translation of Harvey murine sarcoma virus RNA. J. Virol. 22, 711-719 (1977).
40. Shih, T. Y., Weeks, M. O., Young, H. A. & Scolnick, E. M. p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation. J. Virol. 31, 546-546 (1979).
41. Shih, T. Y., Weeks, M. O., Young, H. A. & Scolnick, E. M. Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells tranformed by Kirsten or Harvey murine sarcoma virus. Virology 96, 64-79 (1979).
42. Scolnick, E. M., Papageorge, A. G. & Shih, T. Y. Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses. Proc. Natl Acad. Sci. USA 76, 5355-5359 (1979).
43. Willingham, M. C., Pastan, I., Shih, T. Y. & Scolnick, E. M. Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell 19, 1005-1014 (1980).
44. Willumsen, B. M., Chnstensen, A., Hubbert, H. L., Papageorge, A. G. & Lowy, D. R. The p21ras c-terminus is required for transformation and membrane association. Nature 310, 583-586 (1984).
45. Gibbs, J. B., Sigal, I. S., Poe, M. & Scolnick, E. M. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc. Natl Acad. Sci. USA 81, 5704-5708 (1984).
46. McGrath, J. P., Capon, D. J., Goeddel, D. V. & Levinson, A. D. Comparative biochemical properties of normal and activated human ras p21 protein. Nature 310, 644-649 (1984).
47. Sweet, R. W. et al. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature 311, 273-275 (1984).
48. Hudey, J. B., Simon, M. I., Teplow, D. B., Robishaw, J. D. & Gilman, A. G. Homologies between signal transducing G proteins and ras gene products. Science 226, 860-862 (1984).
49. Toda, T. et al. In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell 40, 27-36 (1985).
50. Kamata, T. & Feramisco, J. R. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins. Nature 310, 147-150 (1984).
51. Mulcahy, L. S., Smith, M. R. & Stacey, D. W. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313, 241-243 (1985).
52. Smith, M. R., DeGudicibus, S. J. & Stacey, D. W. Requirement for c-Ras proteins during viral oncogene transformation. Nature 320, 540-543 (1986).
53. Birchmeier C., Broek, D. & Wigler, M. ras proteins can induce meiosis in Xenopus oocytes. Cell 43, 615-621 (1985).
54. Trahey, M. & McCormick, F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238, 542-545 (1987).
55. Trahey, M. et al. Molecular cloning of two types of GAP complementary DNA from human placenta. Science 242, 1697-1700 (1988).
56. Vogel, U. S. et al. Cloning of bovine GAP and its interaction with oncogenic ras p21 Nature 335, 90-93 (1988).
57. Ballester, R. et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast/RA proteins. Cell 63, 851-859 (1990).
58. Martin, G. A. et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843-849 (1990).
59. Wallace, M. R. et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181-186 (1990)
60. Xu, G. et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608 (1990).
61. Broek, D. et al. The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway. Cell 48, 789-799 (1987).
62. Robinson, L. C., Gibbs, J. B., Marshall, M. S., Sigal, I. S. & Tatchell, K. CDC25: a component of the RAS-adenylate cyclase pathway in Saccharomyces cerevisiae. Science 235, 1218-1221 (1987).
63. Wolfman, A. & Macara, I. G. A cytosolic protein catalyzes the release of GDP from p21ras. Science 248, 67-69 (1990).
64. Downward, J., Riehl, R., Wu, L. & Weinberg, R. A. Identification of a nucleotide exchange-promoting activity for p21ras. Proc. Natl Acad. Sci. USA 87, 5998-6002 (1990).
65. Martegani, E. et al. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. EMBO J. 11, 2151-2157 (1992).
66. Bowtell, D., Fu, R., Simon, M. & Senior, P. Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras. Proc. Natl Acad. Sci. USA 89, 6511-6515 (1992).
67. Shou, C., Farnsworth, C. L., Neel, B. G. & Feig, L. A. Molecular cloning of cDNAs encoding a guanine-releasing factor for ras p21. Nature 358, 351-354 (1992).
68. Wei, W. et al. Identification of a mammalian gene structurally and functionally related to the CDC25 gene of Saccharomyces cereviesiae. Proc. Natl Acad. Sci. USA 89, 7100-7104 (1992).
69. Clark, S. G., Stern, M. J. & Horvitz, H. R. C. elegans cell-signaling gene Sem-5 encodes a protein with SH2 and SH3 domains. Nature 356, 340-344 (1992).
70. Lowenstein, E. J. et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to Ras signalling. Cell 70, 431-442 (1992).
71. Matuoka, K., Shibata, M., Yamakawa, A. & Takenawa, T. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries. Proc. Natl Acad. Sci. USA 89, 9015-9019 (1992).
72. McCormick, F. Signal transduction. How receptors turn Ras on. Nature 363, 15-16 (1993).
73. Rapp, U. R. & Todaro, G. J. Generation of oncogenic mouse type C viruses: in vitro selection of carcinoma-inducing variants. Proc. Natl Acad. Sci. USA 77, 624-628 (1980).
74. Moodie, S. A., Willumsen, B. M., Weber, M. J. & Wolfman, A. Complexes of Ras, GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260, 1658-1661 (1993).
75. Warne, P. H., Rodriguez-Viciana, P. & Downward, J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364, 352-355 (1993).
76. Zhang, X. F. et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364, 308-313 (1993).
77. Vojitek, A. B., Hollenbarg, S. M. & Cooper, J. A. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205-214 (1993).
78. Han, M., Golden, A., Han, Y. & Sternberg, P. W. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature 363, 133-140 (1993).
79. Sjolander, A., Yamamoto, K., Huber, B. E. & Lapetina, E. G. Association of p21ras with phosphatidylinositol 3-kinase. Proc. Natl Acad. Sci. USA 88, 7908-7912 (1991).
80. Kazlauskas, A. Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev. 4, 5-14 (1994).
81. Rodriguez-Viciana, P. et al. Phosphatidylinositol-3-OH kinase as a direct target for ras. Nature 370, 527-532 (1994).
82. Hofer, F., Fields, S., Schneider, C. & Martin, G. S. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl Acad. Sci. USA 91, 11089-11093 (1994).
83. Kikuchi, A., Demo, S. D., Ye, Z. H., Chen, Y. W. & Williams, L. T. ralGDS family members interact with the effector loop of ras p21. Mol. Cell. Biol. 14, 7483-7491 (1994).
84. Spaargaren, M. & Bischoff, J. R. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc. Natl Acad. Sci. USA 91, 12609-12613 (1994).
85. Schafer, W. R. et al. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science 245, 379-385 (1989).
86. Schafer, W. R. et al. Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein. Science 249, 1133-1139 (1990).
87. Reiss, Y., Goldstein, J. L., Seabra, M. C., Casey, P. J. & Brown, M. S. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell 62, 81-88 (1990).
88. Kohl, N. E. et al. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med. 1, 792-797 (1995).
89. Nagasu, T., Yoshimatsu, K., Rowell, C., Lewis, M. D. & Garcia, A. M. Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. Cancer Res. 55, 5310-5314 (1995).
90. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nature Rev. Cancer 3, 11-22 (2003).
91. Vos, A. M. et al. Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science 239, 888-893 (1988).
92. Pai, E. F. et al. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature 341, 209-214 (1989).
93. Schlichting, I. et al. Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis. Nature 345, 309-315 (1990).
94. Krengel, U. et al. Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell 62, 539-548 (1990).
95. Tong, L. A., de Vos, A. M., Milburn, M. V. & Kim, S. H. Crystal structures at 2.2 Å resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. J. Mol. Biol. 217, 503-516 (1991).
96. Scheffzek, K. et al. The Ras-RasGAP complex: structural basis for GTPase activation and itss loss in oncogenic Ras mutants. Science 277, 333-338 (1997).
97. Ahmadian, M. R. et al. Guanosine triphosphatase stimulation of oncogenic Ras mutants. Proc. Natl Acad. Sci. USA 96, 7065-7070 (1999).
98. Boriack-Sjodin, P. A. et al. The structural basis of the activation of Ras by Sos. Nature 394, 337-343 (1998).
99. Huang, L., Hofer, F., Martin, G. S. & Kim, S. H. Structural basis for the interaction of Ras with RalGDS. Nature Struct. Biol. 5, 422-426 (1998).
100. Pacold, M. E. et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103, 931-943 (2000).
101. Reuther, G. W. & Der, C. J. The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr. Opin. Cell Biol. 12, 157-165 (2000).
102. Johnson, L. et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11, 2468-2481 (1997).
103. Koera, K. et al. K-ras is essential for the development of the mouse embryo. Oncogene 15, 1151-1159 (1997).
104. Esteban, L. M. et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21, 1444-1452 (2001).
105. Bivona, T. G. & Philips, M. R. Ras pathway signaling on endomembranes. Curr. Opin. Cell Biol. 15, 136-142 (2003).
106. Hamad, N. M. et al. Distinct requirements for Ras oncogenesis in human versus mouse calls. Genes Dev. 16, 2045-2057 (2002).
107. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002).
108. Balmain, A., Ramsden, M., Bowden, G. T. & Smith, J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307, 658-660 (1984).
109. Zarbl, H., Sukumar, S., Arthur, A., Martin-Zanca, D. & Barbacid, M. Direct mutagenesis of H-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315, 382-385 (1985).
110. Wiseman, R. W., Stowers, S. J., Miller, E. C., Anderson, M. W. & Miller, J. A. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc Natl Acad. Sci. USA 83. 5825-5829 (1986).
111. Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468-472 (1999).
112. Fisher, G. H. et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15, 3249-3262 (2001).
113. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
114. Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248 (2001).
115. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R. & Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49, 465-475 (1987).
116. Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter R. D. & Brinster, R. L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48, 1023-1034 (1987).
117. Umanoff, H., Edelmann, W., Pellicer, A. & Kucherlapati, R. The murine N-ras gene is not essential for growth and development. Proc. Natl Acad. Sci. USA 92, 1709-1713 (1995).
118. Pérez de Castro, I. et al. Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res. 63, 1615-1622 (2003).
119. Ise, K. et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19, 2951-2956 (2000).